Trailing-twelve-month (TTM) revenue is $6.72 Billion with a year-over-year growth of (5.41%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q1 FY2026Period ended 2025-09-30 | $1,429,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-03 |
| Q2 FY2026Period ended 2025-12-31 | $1,673,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-03 |
| Q3 FY2026Period ended 2026-03-31 | $1,670,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-30 |
| Q4 FY2026Period ended 2026-06-30 | $1,948,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-07 |
| TTM revenue | $6,720,000,000 |
Current P/S: $10,836,940,020 market capitalization ÷ $6,720,000,000 TTM revenue = 1.61x.
Market capitalization source: FMP quote. Quote observed 2026-09-09T20:00:02.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q4 FY2026 (2026-06-30): $1.95B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T20:00:02.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-06-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-06-30 · USD | FY20222022-06-30 · USD | FY20232023-06-30 · USD | FY20242024-06-30 · USD | FY20252025-06-30 · USD | FY20262026-06-30 · USD |
|---|---|---|---|---|---|---|
| Health and Wellness | $3.0B | $2.7B | $2.5B | $2.5B | $2.7B | $2.7B |
| Household | $2.0B | $2.0B | $2.1B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-06-30 · USD | FY20222022-06-30 · USD | FY20232023-06-30 · USD | FY20242024-06-30 · USD | FY20252025-06-30 · USD | FY20262026-06-30 · USD |
|---|---|---|---|---|---|---|
| Foreign | N/A | N/A | N/A | N/A | $1.0B | $1.1B |
| International | $1.1B | $1.2B | $1.2B |
$6.72B
$6.72 Billion
(5.41%)
vs. $7.10B a year ago (TTM)
(1.75%)
5 Year compound annual growth rate
1 Year
(5.41%)
3 Year
(3.11%)
5 Year
(1.75%)
10 Year
+1.55%
15 Year
+1.68%
20 Year
+1.86%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $6.72B | ($384.00M) | (5.41%) |
| 2025 | $7.10B | +$11.00M | +0.16% |
| 2024 | $7.09B | ($296.00M) | (4.01%) |
| 2023 | $7.39B | +$282.00M | +3.97% |
| 2022 | $7.11B | ($234.00M) | (3.19%) |
| 2021 |
TTM Growth
(5.41%)
3-Year CAGR
(3.11%)
5-Year CAGR
(1.75%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-09T20:00:02.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
2026-06-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $2.0B |
| $1.8B |
| International | $1.2B | $1.2B | $1.2B | $1.2B | $1.1B | $1.1B |
|---|
| Lifestyle | $1.2B | $1.3B | $1.3B | $1.3B | $1.3B | $1.1B |
|---|
| N/A |
| N/A |
| UNITED STATES | $6.2B | $6.0B | $6.2B | $6.0B | $6.1B | $5.6B |
|---|
| $7.34B |
| +$620.00M |
| +9.22% |
| 2020 | $6.72B | +$507.00M | +8.16% |
| 2019 | $6.21B | +$90.00M | +1.47% |
| 2018 | $6.12B | +$151.00M | +2.53% |
| 2017 | $5.97B | +$212.00M | +3.68% |
